Patent: Difference between revisions
Jump to navigation
Jump to search
imported>Robert Badgett m (→United States) |
imported>Robert Badgett |
||
Line 1: | Line 1: | ||
===United States=== | ===United States=== | ||
In the [[United States]], the duration of a patent is:<ref name="urlPatent Term Restoration">{{cite web |url=http://www.fda.gov/CDER/about/smallbiz/patent_term.htm |title=Frequently Asked Questions on the Patent Term Restoration Program|author=Anonymous |authorlink= |coauthors= |date=May 12, 2008 |format= |work= |publisher=US Food and Drug Administration |pages= |language= |archiveurl= |archivedate= |quote= |accessdate=2009-01-11}}</ref> | In the [[United States]], the duration of a patent is:<ref name="urlPatent Term Restoration">{{cite web |url=http://www.fda.gov/CDER/about/smallbiz/patent_term.htm |title=Frequently Asked Questions on the Patent Term Restoration Program|author=Anonymous |authorlink= |coauthors= |date=May 12, 2008 |format= |work= |publisher=US Food and Drug Administration |pages= |language= |archiveurl= |archivedate= |quote= |accessdate=2009-01-11}}</ref> | ||
Line 12: | Line 5: | ||
However, patents for products such as food additives and drugs that require approval by federal entities such as the US [[Food and Drug Administration]] prior to marketing, can have a maximum of 5 years extended to the patent to compensate for marketing time lost while waiting for approval." In all cases, the total patent life for the product with the patent extension cannot exceed 14 years from the product’s approval date, or in other words, 14 years of potential marketing time. "<ref name="urlPatent Term Restoration"/><ref name="urlwww.fda.gov">{{cite web |url=http://www.fda.gov/bbs/topics/speech/spe00001.htm |title= Statement by Stuart Nightingale, M.D. Associate Commissioner For Health Affairs U.S. Food and Drug Administration Public Health Service Department Of Health And Human Services Before the Subcommittee on Patents, Copyrights and Trademarks Committee on the Judiciary United States Senate |author=Nightingale, S |authorlink= |coauthors= |date=August 1, 1991 |format= |work= |publisher=US Food and Drug Administration |pages= |language= |archiveurl= |archivedate= |quote= |accessdate=2009-01-11}}</ref> | However, patents for products such as food additives and drugs that require approval by federal entities such as the US [[Food and Drug Administration]] prior to marketing, can have a maximum of 5 years extended to the patent to compensate for marketing time lost while waiting for approval." In all cases, the total patent life for the product with the patent extension cannot exceed 14 years from the product’s approval date, or in other words, 14 years of potential marketing time. "<ref name="urlPatent Term Restoration"/><ref name="urlwww.fda.gov">{{cite web |url=http://www.fda.gov/bbs/topics/speech/spe00001.htm |title= Statement by Stuart Nightingale, M.D. Associate Commissioner For Health Affairs U.S. Food and Drug Administration Public Health Service Department Of Health And Human Services Before the Subcommittee on Patents, Copyrights and Trademarks Committee on the Judiciary United States Senate |author=Nightingale, S |authorlink= |coauthors= |date=August 1, 1991 |format= |work= |publisher=US Food and Drug Administration |pages= |language= |archiveurl= |archivedate= |quote= |accessdate=2009-01-11}}</ref> | ||
Revision as of 08:42, 29 January 2009
United States
In the United States, the duration of a patent is:[1]
- 17 years for patents issued before June 8, 1995
- 20 years for patents issued after June 8, 1995
However, patents for products such as food additives and drugs that require approval by federal entities such as the US Food and Drug Administration prior to marketing, can have a maximum of 5 years extended to the patent to compensate for marketing time lost while waiting for approval." In all cases, the total patent life for the product with the patent extension cannot exceed 14 years from the product’s approval date, or in other words, 14 years of potential marketing time. "[1][2]
- ↑ 1.0 1.1 Anonymous (May 12, 2008). Frequently Asked Questions on the Patent Term Restoration Program. US Food and Drug Administration. Retrieved on 2009-01-11.
- ↑ Nightingale, S (August 1, 1991). Statement by Stuart Nightingale, M.D. Associate Commissioner For Health Affairs U.S. Food and Drug Administration Public Health Service Department Of Health And Human Services Before the Subcommittee on Patents, Copyrights and Trademarks Committee on the Judiciary United States Senate. US Food and Drug Administration. Retrieved on 2009-01-11.